- Home
- RAPT vs SPCE Comparison
RAPT vs SPCE Comparison
Compare RAPT & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- SPCE
- Stock Information
- Founded
- RAPT 2015
- SPCE 2017
- Country
- RAPT United States
- SPCE United States
- Employees
- RAPT N/A
- SPCE N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- SPCE Transportation Services
- Sector
- RAPT Health Care
- SPCE Consumer Discretionary
- Exchange
- RAPT Nasdaq
- SPCE Nasdaq
- Market Cap
- RAPT 122.9M
- SPCE 133.5M
- IPO Year
- RAPT 2019
- SPCE N/A
- Fundamental
- Price
- RAPT $11.74
- SPCE $2.98
- Analyst Decision
- RAPT Buy
- SPCE Hold
- Analyst Count
- RAPT 5
- SPCE 5
- Target Price
- RAPT $33.60
- SPCE $11.05
- AVG Volume (30 Days)
- RAPT 105.9K
- SPCE 3.9M
- Earning Date
- RAPT 08-07-2025
- SPCE 08-06-2025
- Dividend Yield
- RAPT N/A
- SPCE N/A
- EPS Growth
- RAPT N/A
- SPCE N/A
- EPS
- RAPT N/A
- SPCE N/A
- Revenue
- RAPT N/A
- SPCE $1,698,000.00
- Revenue This Year
- RAPT N/A
- SPCE N/A
- Revenue Next Year
- RAPT N/A
- SPCE $4,020.33
- P/E Ratio
- RAPT N/A
- SPCE N/A
- Revenue Growth
- RAPT N/A
- SPCE N/A
- 52 Week Low
- RAPT $5.67
- SPCE $2.18
- 52 Week High
- RAPT $26.56
- SPCE $8.19
- Technical
- Relative Strength Index (RSI)
- RAPT 58.44
- SPCE 38.62
- Support Level
- RAPT $10.20
- SPCE $2.92
- Resistance Level
- RAPT $13.50
- SPCE $3.09
- Average True Range (ATR)
- RAPT 1.01
- SPCE 0.21
- MACD
- RAPT -0.05
- SPCE -0.12
- Stochastic Oscillator
- RAPT 77.46
- SPCE 5.14
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.